top of page
home-logo.png

About Us

DISCOVER OUR STORY AND VISION

Abstract sculpture

Cell and Gene Therapies (CGTx): A Life-Saving Pillar of Medicine with Unmet Potential

Cell and gene therapies (CGTx) represent a groundbreaking advancement in modern medicine, offering transformative treatments for previously incurable conditions. Despite their remarkable potential, several challenges hinder the full realization of their benefits. These include regulatory complexities, high production costs, and limited accessibility. Overcoming these obstacles is crucial to unlocking the full therapeutic power of CGTx, ensuring that patients worldwide can benefit from these innovative, life-saving therapies.

  1. Value chain is fractured and bottlenecked

  2. An ecosystem with diverging incentives

  3. Established legacy processes are inefficient

Screenshot 2024-10-16 at 21.04.11.png

As living drugs, cell and gene therapies do not fit into the standard drug development paradigm.

With product-centric approach, development  expertise, and access to innovation, Volnay can drive the future of Cell & Gene Therapies

Screenshot 2024-10-16 at 21.07.19.png

Innovation

Agility
Speed

bottom of page